Skip to content

Contractile Properties of Hypertrofic Muscles in Patients With Non-Dystrophic Myotonia

Contractile Properties of Hypertrofic Muscles in Patients With Non-Dystrophic Myotonia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04799366
Enrollment
36
Registered
2021-03-16
Start date
2021-02-01
Completion date
2021-12-01
Last updated
2023-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myotonia Congenita, Non-Dystrophic Myotonia

Brief summary

In myotonia congenita (MC), mutations in the CLCN1 gene coding a key chloride channel expressed in muscle cells cause myotonia. On examination, the myotonia can be demonstrated as delayed muscle relaxation of muscle contractions after mechanical stimulations. Existing literature describe no muscle weakness in MC patients, however a recent muscle MRI study in non-dystrophic myotonia patients found structural abnormalities in affected muscles when examined using T1 and STIR imaging. The question remains whether the signs of structural changes in the muscle are merely due to the myotonia, or long-term effects of elevated stress of the tissue, and if so, whether those changes lead to clinically significant loss of contractile properties of the muscle. This study examines if the contractile properties of myotonic muscles are impaired in MC patients. 40 patients with Thomsens disease (n=20) and Beckers disease (n=20), respectively, will be included along with 20 healthy controls. Peak muscle torque is measured in the hand by hand dynamometer and in the thigh and calf muscles with a Biodex System 4 Pro Dynamometer and the cross-sectional area of the muscles are examined on T1-weighed and Dixon-MRI-scan. With the obtained data peak torque in strength tests, muscle hypertrophy, fat fraction in muscle tissue and contractility of the muscles, compared with healthy controls, will be assessed.

Interventions

None listed

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age \<18 years * Molecularly verified MC (Thomsens or Beckers disease)

Exclusion criteria

* Conditions that may impair results of the study, evaluated by the investigator * Clausphobia * Pregnancy or breastfeeding * Metallic objects in and around the body that are not MR-compatible

Design outcomes

Primary

MeasureTime frameDescription
Contractile properties1 yearTo investigate if contractile properties of the muscles are impaired in MC patients compared with healthy controls.

Secondary

MeasureTime frameDescription
Measuring muscle hypertrophy in upper and lower limbs1 yearVisualizing and measuring hypertrophy on MRI of affected muscles in the forearm, thigh and calf of MC patients compared with muscles in healthy controls.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026